Author

Georgio Hawi

The University of SydneyORCID 0009-0008-6093-8769Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 3 Organism:human· 3 Assay:bulk RNA-seq· 2 Approach:statistical model· 2 Research Focus:cell signaling & trafficking· 1 Approach:diffusion model· 1 Research Focus:host-pathogen & immune response· 1 Approach:mechanistic / dynamical model· 1

Frequent Co-Authors

Peter KimiD· 3 shared Peter P. LeeiD· 2 shared Cristina KoprinskiiD· 1 shared

Activity by Year

2026-2026 · peak 3/yr

Co-Author Collaboration Network

3 top collaborators · 2 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Peter KimORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologyJournal of Theoretical BiologyPeer-reviewedMay 12, 2026

Optimisation of pembrolizumab therapy for de novo metastatic MSI-H/dMMR colorectal cancer using data-driven delay integro-differential equations

Georgio Hawi, Peter Kim, Peter P. Lee

This study optimizes pembrolizumab therapy for de novo metastatic MSI-H/dMMR colorectal cancer using delay integro-differential equations, balancing efficacy, efficiency, and toxicity.

2 citations

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologyJournal of Theoretical BiologyPeer-reviewedFeb 4, 2026

Optimising Chemotherapy for Advanced High-Grade Serous Ovarian Cancer via Delay-Differential Equations

Cristina Koprinski, Georgio Hawi, Peter Kim

The paper develops a delay-differential equation model of HGSOC to optimize chemotherapy regimens, finding that low-dose frequent dosing reduces toxicity while maintaining efficacy.

1 citation

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologyBulletin of Mathematical BiologyPeer-reviewedFeb 2, 2026

Modelling Immune Dynamics in Locally Advanced MSI-H/dMMR Colorectal Cancer with Neoadjuvant Pembrolizumab Treatment: From Differential Equations to an Agent-Based Framework

Georgio Hawi, Peter Kim, Peter P. Lee

This paper develops a differential equation model and converts it to an agent-based model to simulate immune dynamics in MSI-H/dMMR colorectal cancer under pembrolizumab treatment.

1 citation

humandiffusion model

𝕏 PostBluesky